These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 15588465

  • 1. Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness.
    Gerli S, Casini ML, Unfer V, Costabile L, Mignosa M, Di Renzo GC.
    Reprod Biomed Online; 2004 Nov; 9(5):494-9. PubMed ID: 15588465
    [Abstract] [Full Text] [Related]

  • 2. Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study.
    Seckin B, Yumusak OH, Tokmak A.
    J Obstet Gynaecol; 2021 Nov; 41(8):1234-1239. PubMed ID: 33624571
    [Abstract] [Full Text] [Related]

  • 3. Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.
    Gerli S, Casini ML, Unfer V, Costabile L, Bini V, Di Renzo GC.
    Fertil Steril; 2004 Sep; 82(3):573-8. PubMed ID: 15374698
    [Abstract] [Full Text] [Related]

  • 4. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N, van Wely M, van Der Veen F.
    Cochrane Database Syst Rev; 2001 Sep; (2):CD002121. PubMed ID: 11406034
    [Abstract] [Full Text] [Related]

  • 5. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.
    Revelli A, Poso F, Gennarelli G, Moffa F, Grassi G, Massobrio M.
    Reprod Biol Endocrinol; 2006 Jul 18; 4():38. PubMed ID: 16848893
    [Abstract] [Full Text] [Related]

  • 6. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS, Nahuis M, Bayram N, Mol BW, Van der Veen F, van Wely M.
    Cochrane Database Syst Rev; 2015 Sep 09; (9):CD010290. PubMed ID: 26350625
    [Abstract] [Full Text] [Related]

  • 7. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S, Gunby J.
    Cochrane Database Syst Rev; 2000 Sep 09; (4):CD002810. PubMed ID: 11034767
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S, Gunby J.
    Cochrane Database Syst Rev; 2007 Jul 18; 2006(3):CD002810. PubMed ID: 17636708
    [Abstract] [Full Text] [Related]

  • 10. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
    Demirol A, Gurgan T.
    Hum Reprod; 2007 Jan 18; 22(1):97-100. PubMed ID: 16954409
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH: a retrospective case- controlled analysis.
    Ravhon A, Lavery S, Aurell R, Trew G, Margara R, Winston R.
    Fertil Steril; 2001 May 18; 75(5):920-5. PubMed ID: 11334903
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
    Palomba S, Falbo A, Orio F, Manguso F, Russo T, Tolino A, Annamaria C, Dale B, Zullo F.
    Hum Reprod; 2005 Oct 18; 20(10):2879-86. PubMed ID: 15958399
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.